Table 1.
Baseline values of the study subjects are given as median and minimum and maximum
| Groups | Control | Levosimendan | Dobutamine | Dobutamine+Levosimendan |
|---|---|---|---|---|
| Weight (g) |
286 (260-313) |
219 (268-336) |
292 (269-338) |
295 (255-315) |
| Heart rate/minute |
348 (238-427) |
349 (309-400) |
381 (230-456) |
343 (233-481) |
| Systolic blood pressure (mmHg) |
113 (105-129) |
122 (105-131) |
112 (94-150) |
117 (96-134) |
| Diastolic blood pressure (mmHg) |
67 (52-86) |
78 (54-86) |
72 (48-100) |
65 (45-87) |
| Mean blood pressure (mmHg) |
82 (70-100) |
93 (71-101) |
81 (63-116) |
84 (67-97) |
| QRS width (s) |
0.023 (0.022-0.025) |
0.022 (0.019-0.026) |
0.022 (0.019-0.026) |
0.023 (0.020-0.026) |
| Arterial blood pH |
7.33 (7.14-7.39) |
7.31 (7.23-7.42) |
7.36 (7.21-7.38) |
7.34 (7.24-7.39) |
| Arterial blood pO2 (mmHg) |
182 (118-216) |
148 (105-219) |
153 (128-288) |
149 (118-288) |
| Arterial bood pCO2 (mmHg) | 30 (21-39) | 29 (28-38) | 30 (26-38) | 33 (24-42) |
Comparison between four groups showed no statistically significant difference.